Have your parents or grandparents ever had trouble driving, reading or recognizing faces? They might be suffering from ...
GA, the advanced form of dry age-related macular degeneration (AMD), poses a significant ... GA results in well-demarcated areas of atrophy within the macula, the central region of the retina ...
Prevent Blindness announces its fourth annual Geographic Atrophy Awareness Week, December 2 to 8, 2024. The organization ...
Geographic atrophy (GA) is the advanced stage of age-related macular degeneration. While certain factors, like age and genetics, can increase your risk, others, like not smoking, may help slow or ...
The following is a summary of “Phase 1 Study of JNJ-81201887 Gene Therapy in Geographic Atrophy Secondary to Age-Related ...
New data presented at the American Society of Retina Specialists 2024 examine the benefits and adverse event profiles of two therapies recently approved to treat dry age-related macular ...
Key findings include reduced lesion growth, retinal tissue preservation, and improved visual function, demonstrating ...
A new study has linked moderate-to-severe obstructive sleep apnea (OSA), characterized by low oxygen levels overnight, with an increased risk of developing wet age-related macular degeneration (AMD).
Apellis Pharma has become the first company to claim FDA approval for a drug to treat geographic atrophy (GA), a sight-robbing condition that accompanies age-related macular degeneration (AMD ...